Skip to content

Neuropsychological Testing in Patients Undergoing Transvascular Aortic Valve Implantation

Neuropsychological Testing in Patients Undergoing TAVI

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01648309
Acronym
TAVIPSYCH
Enrollment
0
Registered
2012-07-24
Start date
2012-09-30
Completion date
2014-09-30
Last updated
2016-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Stenosis

Keywords

aortic stenosis, TAVI, neuropsychological, cognitive, candidates for TAVI

Brief summary

The purpose of this study is to examine the neuropsychological effects of transvascular aortic valve implantation (TAVI). Patients undergoing TAVI usually suffer from congestive heart failure and low cardiac output which may limit their cognitive abilities. TAVI results in significant improvements in cardiac function and therefore may improve cognitive functions. However, TAVI may also be associated with stroke and may therefore have a negative impact on cognition. Therefore, in this study the investigators wish to perform a battery of standardized neuropsychological tests before and after TAVI to test the net effects of TAVI on cognitive performance over time. The investigators plan to include all patients planned to have TAVI in the study and to test them before, 3,7, 30 and 360 days post TAVI with a standardized battery of test.

Interventions

OTHERNeuropsychological testing

This is an observational study

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients with severe aortic stenosis that are candidates for TAVI * Able to perform the testing * Able to sign informed consent

Exclusion criteria

* Language barriers precluding the administration of the testing * Existing dementia * Existing disease limiting life expectancy to less than 180 days

Design outcomes

Primary

MeasureTime frameDescription
net change in neuropsychological tests between baseline and day 180 from TAVI180 daysThe study will assess changes in cognitive performance between baseline (prior to TAVI) and 180 days after TAVI

Secondary

MeasureTime frameDescription
net difference between cognitive measures before TAVI and at day 30 after TAVI30 daysThe study will evaluate net differences between scores obtained on cognitive tests at baseline prior to TAVI and day 30 after TAVI

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026